Current Treatments
BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis

AVONEX® (Interferon beta-1a) is a 166 amino acid glycoprotein with a predicted molecular weight of approximately 22,500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of AVONEX® is identical to that of natural human interferon beta.

COPAXONE is the brand name for glatiramer acetate (formerly known as copolymer-1). Glatiramer acetate, the active ingredient of COPAXONE, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.

Rebif® (interferon beta-1a) is a purified 166 amino acid glycoprotein with a molecular weight of approximately 22,500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of Rebif® is identical to that of natural fibroblast derived human interferon beta. Natural interferon beta and interferon beta-1a (Rebif®) are glycosylated with each containing a single N-linked complex carbohydrate moiety.

Tysabri is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Tysabri is used to treat relapsing forms of multiple sclerosis. 		Gilenya™ is a new class of medication called a phingosine 1-phosphate receptormodulator, which is thought to act by retaining certain white blood cells (lympohcytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.

Early Symptoms
The most common early symptoms of MS include:
* Tingling * Numbness
* Loss of balance
* Weakness in one or more limbs
* Blurred or double vision

Less common symptoms of MS may include
* Slurred speech
* Sudden onset of paralysis
* Lack of coordination
* Cognitive difficulties
Listed above, the early symptoms. I tend to be a poster child for these. The symptoms that occur later on are too numerous just to list. There will be a link included that will get you to a site where these symptoms are listed and explained. Keep in mind that someone may have some of these or many of these, there is no way to tell.
Multiple sclerosis statistics show that approximately 250,000 to 350,000 people in the United States have been diagnosed with this disease. The life expectancy for people with multiple sclerosis is nearly the same as for those without MS. Because of this, multiple sclerosis statistics place the annual cost of MS in the United States in the billions of dollars. MS is five times more prevalent in temperate climates -- such as those found in the northern United States, Canada, and Europe -- than in tropical regions. Furthermore, the age of 15 seems to be significant in terms of risk for developing the disease. Some studies indicate that a person moving from a high-risk (temperate) to a low-risk (tropical) area before the age of 15 tends to adopt the risk (in this case, low) of the new area and vice versa. Other studies suggest that people moving after age 15 maintain the risk of the area where they grew up.

Tuesday, September 25, 2012

The one thing every family deserves

Dear Stephen, For many families, a diagnosis of MS can change everything: Daily activities become increasingly challenging. Children carry adult-sized responsibilities. Family milestones are cut short—or missed altogether. But you can help us change all that. The good news is that research is advancing faster. Families are receiving more resources and support than ever. But we can't stop now. Every day and every dollar gets us one step closer to stopping MS and changing lives. Will you join the movement by making a donation today to support families and move us closer to a world free of MS? With your help, we can end MS forever, ensuring that one day every mom, dad, and grandparent will be there for all of life's milestones. Now that's a happy memory. Sincerely, Krista Asteriadis Byers Associate Vice President of Individual Giving National MS Society P.S. The Society understands that every person's situation and financial abilities are different. If you or a loved one are living with MS and need help, please visit this toolkit for valuable family resources. Your gift directly helps: fund cutting-edge research to end MS, provide resources and support to families, protect future generations from the uncertainty of MS National MS Society | View as Web page | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe MS stops people from moving. The National MS Society exists to make sure it doesn't. We are a collective of passionate individuals, moving together to create a world free of MS. JOIN THE MOVEMENT® Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS® or Walk MS® — or to contact National MS Society staff in your area — please visit our Web site. Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at www.nationalMSsociety.org or 1-800-344-4867. National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017 This message was sent to wrennstephen844@gmail.com . To ensure that you continue to receive our e-mails, please add us to your address book. ©2012 National Multiple Sclerosis Society. All rights reserved.
Posted by Steve at Tuesday, September 25, 2012

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

About Me

My photo
North Grafton, Massachusetts, United States
Well-educated, disabled at this point with Multiple Sclerosis. I am very glad that I was able to do the things that I have been able to do over the years. had to change the picture, this one's more realistic.